CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	8 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Cash Flows from Operating Activities:
Net loss	$ (606,308)	$ (9,226,679)
Adjustments to reconcile net loss to net cash used in operating activities:
Operating costs allocated to the issuance of the over-allotment option	7,119
Gain on issuance of over-allotment option	(62,100)
Interest income on investments held in Trust Account	(3,533)	(930,531)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(478,221)	200,814
Accounts payable and accrued expenses	31,000	2,022,042
Due to related parties	(12,134)	153,618
Accrued advisory fees		7,000,000
Income tax payable		133,602
Franchise taxes payable	137,534	(37,945)
Net cash used in operating activities	(986,643)	(685,079)
Cash Flows from Investing Activities:
Cash deposited into Trust Account	(173,472,000)
Net cash used in investing activities	(173,472,000)
Cash Flows from Financing Activities:
Proceeds from sale of common stock to Sponsor	25,000
Proceeds from convertible note - related party	60,000	395,000
Proceeds from initial public offering, net of underwriter's discount paid	163,464,000
Proceeds from sale of Private Placement Shares	11,908,000
Payment of offering costs	(330,126)	(70,000)
Net cash provided by financing activities	175,126,874	325,000
Net Change in Cash	668,231	(360,079)
Cash - Beginning of Period	0	494,693
Cash - End of Period	668,231	134,614
Supplemental disclosures of investing and financing activities:
Payment of dividend to Class A Public Shareholders from trust account	834,000	3,336,000
Supplemental disclosures of noncash investing and financing activities:
Remeasurement of Class A common stock subject to redemption to redemption value	9,668,115	$ 402,599
Forfeiture of Class B common stock	14
Deferred offering costs included in due to related parties	11,363
Deferred underwriting fee payable	$ 5,838,000